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ABSTRACT
Phenylpropanolamine (PPA) hydrochloride used as nasal decongestant agent was determined by second derivative spectrophotometry after derivatization with 2-hydroxynaphthaldehyde.  The absorbance was measured between minimum-maximum of 386 nm-392
nm.  The linear calibration range was obtained within 0.5~2.0 µg/mL.  The method was applied for the determination of phenylpropanolamine from pharmaceutical preparations Tavegyl-D and Sinutab with coefficient of variation of 0.8~1.6%.  Paracetamol present
together with phenylpropanolamine could also be determined by spectrophotometry in aqueous phase after extraction of PPA in chloroform.
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INTRODUCTION
P h e n y l p r o p a n o l a m i n e H C l ( P PA · H C l ) i s a
sympathomimetic agent with vascoconstriction and
decongestant effect on inflammed mucous membranes.  
It is also reported as an appetite suppressant.   Recently,
considerable interest in PPA·HCl has arisen due to
the serious side effects accompanied its use including
hemorrhage stroke, arrhythmis and hypertension(1-2).  A
number of analytical methods have been reported for
the determination of PPA based on spectrofluorimetry(3),
room temperature phosphorescence (4) , fluroammuno
assay(5), radioenzymatic assay(6), Raman spectroscopy(7),
capillary zone electrophoresis (8), thin layer (9), gas (9-11)
and liquid chromatography(12-18).  The spectrophotometer
methods are simple and required sensitivity could be
achieved by employing suitable derivatizing reagent.  The
spectrophotometric methods for PPA are based on the
measurement of absorbance within UV region, or recording
the absorbance in visible region after derivatization(19-27).
Tan and Kolmonpunpon (28) reported second-derivative
spectra with maxima at 260 and minima at 257 nm with
calibration range within 20~350 µg/mL.  The present work
examines a sensitive method for PPA, based on secondderivative spectrophotometry after derivatization with
2-hydroxynaphthaldehyde (HN).

MATERIALS AND METHODS
Phenylpropanolamine HCl (Novartis, Pak.),
paracetamol (Pharmatec (Pvt) Ltd. Karachi),
2-hydroxynaphthaldehyde (HN) (Fluka), methanol,
chloroform (E. Merck) and sodium hydroxide (Fluka) were
* Author for correspondence. Tel: +92-22-2771443, +92-22-2772325
Fax: +92-22-2771372; E-mail: rm_arain_su@yahoo.com

used.   Spectorphotometric studies were carried out using
Hitachi 220-spectrophotometer.
I. Spectrophotometric Determination
An aqueous solution containing 12.5 to 50 µg of
PPA·HCl and 1.625 to 8.125 mg of paracetamol were
transferred to separating funnel and sodium hydroxide
solution (0.5 mL of 0.2% w/v) was added.  Chloroform
(4 mL) was added and contents were thoroughly mixed.  
The layers were allowed to separate and the organic layer
was collected in 25-mL volumetric flasks.  The extraction
was repeated with chloroform (4 mL) and to the combined
extract was added 2-hydroxynaphthaldehyde (HN) (2
mL, 0.3% w/v in methanol) and acetic acid (0.5mL).  The
contents were heated on water bath at 70~75°C for 10 min
and its volume was adjusted to mark with methanol.  Second
derivative absorption spectrum was recorded in the range:
430 nm to 250 nm against reagent blank with scan speed:
60 nm/min, chart speed: 20 nm/cm and response time: 1
sec, slit width: 2 nm and scale: 0~1 A.  The quantitation was
carried out by measuring the amplitude of peaks obtained
between maxima at 392 nm and minima at 386 nm.
The aqueous layer remaining in the separating funnel
was collected in another volumetric flask (25 mL) and the
volume was adjusted with water.  The absorbance of the
solution was measured against water at 291 nm.
II. Determination of Phenylpropanolamine and Paracetamol
in Pharmaceutical Preparations
Ten tablets each of Tavegyl-D (Sandoz (Pak.) Ltd.
Karachi) and Sinutab (Park-Davis & Co. (Pak) Ltd.
Karachi) were ground.  An amount of 0.51 g from Travergl
D and 0.0475 g Sinutab tablets were separately dissolved
in water on water bath at 70~80°C.   The solution was
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filtered and the final volume was adjusted to 50 mL with
distilled water.  A solution (1.0 mL) of Travegl-D or (2.0
mL) from Sinutab tablets was transferred to a separating
funnel and the procedure was followed as above.  For the
determination of paracetamol from the Sinutab tablets (10.0
mL) of solution was taken and procedure was followed
as above.   The amounts of PPA and paracetamol from
the pharmaceutical preparations were evaluated from the
calibration curves.

Phenylpropanolamine hydrochloride (PPA·HCl) in
aqueous solution absorbs in UV region at 210 nm and 256
nm with molar absorptivities of 3778 and 156 L·mole-1·cm-1.
In order to increase the spectrophotometric sensitivity for
the determination of PPA, the derivatization with HN was
carried out.
The drug PPA·HCl is soluble in water, but is insoluble
in organic solvents (chloroform, ethyl ether and ethyl
acetate), while the derivatizing reagent HN is readily
soluble in the organic solvents, but is insoluble in water.  
The drug was first treated with sodium hydroxide solution
and the free base was quickly extracted in chloroform.  
The derivatization reaction was carried out in chloroformmethanol media, in the presence of glacial acetic acid.
Initially the absorptiometric studies were carried out
using zero order spectrophotometry, but some difficulties
were encountered in the reproducibility of the determination
because the derivatizing reagent also indicated some
absorbance at the wavelength of maximum absorbance
of the derivative.  The derivative spectrophotometry was
then examined within 430~250 nm against reagent blank.  
Second derivative spectrophotometry gave reproducible
results with improvement in the sensitivity of determination.  
The spectrum was recorded and amplitude was measured
between two wavelengths 392 nm and 386 nm (Figure 2).  
Linear calibration curve was obtained within 0.5~2.0 µg/mL
PPA·HCl with the coefficient of determination (r2) 0.9998
and regression equation y = 0.4385x.  The reproducibility
of the response with 1 µg/mL PPA·HCl was measured (n = 6)
and coefficient of variation was obtained 1.2%.
The effect of heating time and concentration of
derivatizing reagent were examined.  The heating timing at
70~75°C was varied from 5~25 min at an interval of 5 min.  
A similar absorbance was observed after the heating of 5
min and heating time of 10 min was selected.  The reagent
HN concentration was varied between 1~5 mL (0.3% w/v
in methanol) at an interval of 1 mL and a similar response
was obtained with 1~3 mL and addition of 2 mL proved
satisfactory for quantitative derivatization.
PPA·HCl is present in pharmaceutical preparations in
combination with paracetamol, phenyltoloxamine citrate,
clemestine hydrogen fumarate and pheniramine maleate,
hence their possible interfering effects on the determination
of PPA·HCl was investigated.  The study was performed at
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Figure 1. Structural diagram of 2-hydroxynaphthaldehyde derivative
of phenylpropanolamine.
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Figure 2. Second derivative absorption spectra of   derivative of
phenylpropanolamine against reagent blank.  Concentrations: (1) 0.5,
(2) 1.0, (3) 1.5 and (4) 2.0 µg/mL phenylpropanolamine.

the same concentration and 10 times the concentration to
that of PPA·HCl.  PPA is selectively extractive in organic
solvent prior to derivatization; therefore, these drugs do not
affect the determination of PPA·HCl, with the change in
absorbance within 3%.  Similarly, possible additives, such
as lactose, gum accacia, methylparabin, propylparabin,
sorbitol, propylene glycol do not affect the quantitative
response of PPA when added at the concentration of 10
times of that PPA·HCl.
After the extraction of PPA in chloroform, paracetamol
was determined in aqueous phase in alkaline medium.  A
linear calibration curve was obtained, which obeyed the
Beer’s law, in the range of 65~325 µg/mL at 291 nm, with
the coefficient of determination (r 2) 0.9981, y=   0.001x.  
The analysis of test solutions of paracetamol together with
PPA indicated relative error within ±3%.
Finally the method was applied for the determination
of PPA·HCl and paracetamol from pharmaceutical
preparations — Tavegyl-D, Sinutab and Panadol tablets.  
The results (Table 1) obtained indicated the relative
deviation of 3.2~4.8% for both PPA and paracetamol from
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Table 1. Analysis of phenylpropanolamine hydrochloride and paracetamol by second derivative spectrophotometry
Name of  preparation

Compound present

Tavegel-D

Sinutab

Clemestine
(as hydrogen fumarate)
Phenylpropanol-amine
hydrochloride)
Paracetamol

Panadol

Phenylpropanol-amine
hydrochloride
Phenyltoloxamine citrate)
Paracetamol

Amount reported by
manufacturer mg/tablet
1

Amount found mg/tablet
(CV%, n=3)
—

Relative deviation
(%) from reported values
—

75

72.6
(1.3)
311
(1.6)
23.8
(0.8)
—
480.5
(0.9)

3.2

325
25
22
500

the reported values by the manufacturer with the coefficient
of variation (CV) in the range of 0.8~1.3%.

CONCLUSIONS
A simple second derivative spectrophotometric
procedure has been suggested for the determination of
PPA·HCl after derivatization with HN, with the observed
linear calibration within 0.5~2.0 µg/mL.  After extraction of
PPA in chloroform, the paracetamol remaining in aqueous
solution having alkaline medium could also be determined
by spectrophotometry.  The CV for to analysis of PPA·HCl
and paracetamol from pharmaceutical preparations was
observed within 0.8~1.3%.
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